JP Morgan posts $510m XVA gain

Lower funding costs helped JP Morgan book a $510 million gain from derivatives valuation adjustments (XVAs) in Q2, its largest such windfall for at least five years.

The benefit partly offset a $951 million XVA loss in Q1, the biggest on record, caused by a blow out of funding spreads triggered by the coronavirus-induced financial panic.

XVA effects are captured under the “credit adjustments and other” line item in JP Morgan’s quarterly earnings releases, and include all costs and benefits to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: